Skip to main content

The Food and Drug Administration’s Accelerated Approval Process for New Pharmaceuticals - A Workshop

Completed

The workshop examined the use of the accelerated approval authority for pharmaceuticals and lessons learned. It examined the current regulatory framework for accelerated approvals and explored ways to strengthen the accelerated approval process. It also examined comparable expedited pathways used by other nations' regulatory health authorities and lessons learned from their experiences.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.